Cell and Gene Manufacturing and Logistics

  1. Operating And Maintaining Pharmaceutical Gas Distribution Systems 9/12/2025

    Drug manufacturers face stringent requirements when using gas that comes into direct contact with the product. This guide discusses operation, maintenance, and monitoring of gas systems.

  2. Cleanroom Recovery. Proven Results. Contamination Control Case Studies 9/11/2025

    Through this collection, review how a proven, automated solution can help facilities stay compliant, operational, and protected — whether in a crisis or during planned maintenance.

  3. Functional And Phenotypic Characterization Of Human NK Cells Post-Expansion 9/10/2025

    A new method for expanding natural killer cells provides a way to generate a large quantity of potent cells for clinical applications. This approach maintains key cell functions and killing ability.

  4. NK Cell Expansion Using Scale Up Bioreactors For Cell Therapy 9/10/2025

    A feeder-free medium and closed processing system can expand and process primary human NK cells for clinical use, helping researchers overcome a key bottleneck in cell therapy manufacturing.

  5. The Hidden Cost Of Off-The-Shelf Media In Cell Therapy 9/10/2025

    Generic, off-the-shelf media can introduce hidden costs and delays in cell and gene therapy development. A strategic media approach is a critical advantage that can accelerate your path to the clinic.

  6. CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D. 9/9/2025

    Biotech leader Nicole Paulk, Ph.D., joins “Better Biopharma” to discuss Siren Biotechnology’s switch from plasmids to producer cell lines, CGT funding challenges, and the competition that determined which CDMO won Siren’s business.

  7. Protecting The Foundation Of Biologics With Flexible, Scalable Cell Banking 9/9/2025

    Safeguard your cell banks with secure, compliant storage and streamlined delivery solutions that keep manufacturing on schedule and therapies moving forward.

  8. ATMP Development In 2025: Promise, Pressure, And The Push To Scale 9/9/2025

    Drive the next wave of cell and gene therapy innovation by overcoming operational, funding, and regulatory challenges to deliver life-changing treatments to patients faster.

  9. Built For Speed: How To Deliver Without Compromise 9/9/2025

    Ensure fast, reliable, temperature-controlled logistics with a global infrastructure designed to protect critical biologic materials and keep development programs running smoothly and on schedule.

  10. Engineering Off-The-Shelf Cell Therapies For Cancer And Autoimmune Disease With Ernexa Therapeutics' Sanjeev Luther 9/9/2025

    On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Ernexa Therapeutics' President and CEO, Sanjeev Luther, about how the company is advancing cell therapy innovation for cancer and autoimmune disease through engineered induced pluripotent stem cell-derived mesenchymal stem cells (iMSCs).